Načítá se...
Sleep Apnea, Metabolic Disease, and the Cutting Edge of Therapy
Obstructive sleep apnea (OSA) is common, and many cross-sectional and longitudinal studies have established OSA as an independent risk factor for the development of a variety of adverse metabolic disease states, including hypertension, insulin resistance, type 2 diabetes, nonalcoholic fatty liver di...
Uloženo v:
| Vydáno v: | Metabolism |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874161/ https://ncbi.nlm.nih.gov/pubmed/28966076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2017.09.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|